Appili Therapeutics Inc stock $verbed on Friday.
Appili Therapeutics Inc opened trading today at $0.07 and closed at $0.07. It traded at a low of $0.07 to a high of $0.07.
The price $verbed percentage_change percent from the previous day's close of $0.07.
During the day across North America, the TSX Composite closed 0.16% at 19577.04, the S&P 500 closed -0.08% at 4151.94, the Dow Jones Industrial Average closed -0.26% at 32726.82 and the Nasdaq Composite closed 0.41% at 12720.58.
Appili Therapeutics Inc has listed on the TSX stock exchange under the ticker APLI.TO.
A total of 13,812 shares was traded during the last trading day, with total trades of 4. On average, Appili Therapeutics Inc has traded 55,587 shares in the last five days and 180,721 year-to-date.
The TSX market on the whole today saw 2,935 price advancers against 2,628 declines and 246 unchanged.
During the prior 52 weeks, APLI.TO has traded as high as $1.14 (September 30,2021) and low as $0.06 (July 22,2022). Moreover, in the last 52 weeks, Appili Therapeutics Inc's shares have plummeted -90.91%, while they have plummeted -39.13% year-to-date.
Following today's trading, Appili Therapeutics Inc has a market capitalization of $8.49 million on a float of 121,266 shares outstanding. Its annual EPS is $-0.38.
Appili Therapeutics Inc is a None company headquartered in Halifax, US.
Currently, Appili Therapeutics Inc's consensus rating is "Hold" based on 2 analysts according to Zacks. Currently, there are 2 hold ratings for the stock.
Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..